The Latest in Multiple Sclerosis Hub

Blood test could predict future disability in MS

November 14, 2023

Multiple Sclerosis

New evidence early treatment improves preclinical MS outcomes

September 15, 2023

Multiple Sclerosis

Early MS treatment tied to a major reduction in severe disability

July 25, 2023

Multiple Sclerosis

Retinal thickness a new predictor of MS disability?

July 19, 2023

Multiple Sclerosis

High-efficacy therapies for MS: When and how to use them

October 27, 2022

Multiple Sclerosis

Ublituximab bests teriflunomide in head-to-head clinical trials

August 30, 2022

Multiple Sclerosis

Cognitive impairment may predict physical disability in MS

July 11, 2022

Multiple Sclerosis

Risk of drug interactions is on the rise as MS drugs evolve

June 13, 2022

Multiple Sclerosis

Consider the wider picture in relapsing remitting MS

June 13, 2022

Multiple Sclerosis

Inebilizumab beneficial across genotypes in NMOSD

June 10, 2022

Multiple Sclerosis

Stem cell transplants for MS are a ‘reasonable option,’ but questions persist

June 7, 2022

Multiple Sclerosis

MS and COVID-19: Conflicting signs on risk but some trends are clearer

June 7, 2022

Multiple Sclerosis

Non-White subjects are sparse in DMT trials for MS

June 6, 2022

Multiple Sclerosis

B-cell level may affect COVID booster efficacy in MS

June 3, 2022

Multiple Sclerosis

Childhood abuse may increase risk of MS in women

April 20, 2022

Multiple Sclerosis